Second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma: A retrospective analysis of 192 patients from NEJ023 Study.

Authors

Shunichiro Iwasawa

Shunichiro Iwasawa

Department of Medical Oncology, Chiba University Hospital, Chiba, Japan

Shunichiro Iwasawa , Ryo Ko , Takehito Shukuya , Satoshi Watanabe , Yoko Tsukita , Hironori Ashinuma , Taku Nakagawa , Ryo Ito , Kazutsugu Uematsu , Mika Nakao , Yoshiaki Mori , Kyoichi Kaira , Atsuto Mouri , Takao Miyabayashi , Hiroyuki Sakashita , Yoko Matsumoto , Tomoyuki Tanigawa , Satoshi Morita , Kazuhisa Takahashi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Thymic Malignancies

Clinical Trial Registration Number

UMIN000015649

Citation

J Clin Oncol 34, 2016 (suppl; abstr 8569)

DOI

10.1200/JCO.2016.34.15_suppl.8569

Abstract #

8569

Poster Bd #

197

Abstract Disclosures